The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis
- PMID: 23656857
- DOI: 10.4088/JCP.12r07968
The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis
Abstract
Objective: Depression often remains undertreated during pregnancy and there is growing evidence that untoward perinatal outcomes can result. Our systematic review and meta-analysis was conducted to determine whether maternal depression during pregnancy is associated with adverse perinatal and infant outcomes.
Data sources: MEDLINE, EMBASE, CINAHL, and PsycINFO were searched from their start dates to June 2010. Keywords utilized included depressive/mood disorder, postpartum/postnatal, pregnancy/pregnancy trimesters, prenatal or antenatal, infant/neonatal outcomes, premature delivery, gestational age, birth weight, NICU, preeclampsia, breastfeeding, and Apgar.
Study selection: English language studies reporting on perinatal or child outcomes associated with maternal depression were included, 3,074 abstracts were reviewed, 735 articles retrieved, and 30 studies included.
Data extraction: Two independent reviewers extracted data and assessed article quality. All studies were included in the primary analyses, and between-group differences for subanalyses are also reported.
Results: Thirty studies were eligible for inclusion. Premature delivery and decrease in breastfeeding initiation were significantly associated with maternal depression (odds ratio [OR] = 1.37; 95% CI, 1.04 to 1.81; P = .024; and OR = 0.68; 95% CI, 0.61 to 0.76; P < .0001, respectively). While birth weight (mean difference = -19.53 g; 95% CI, -64.27 to 25.20; P = .392), low birth weight (OR = 1.21; 95% CI, 0.91 to 1.60; P = .195), neonatal intensive care unit admissions (OR = 1.43; 95% CI, 0.83 to 2.47; P = .195), and preeclampsia (OR = 1.35; 95% CI, 0.95 to 1.92; P = .089) did not show significant associations in the main analyses, some subanalyses were significant. Gestational age (mean difference = -0.19 weeks; 95% CI, -0.53 to 0.14; P = .262) and Apgar scores at 1 (mean difference = -0.05; 95% CI, -0.28 to 0.17; P = .638) and 5 minutes (mean difference = 0.01; 95% CI, -0.08 to 0.11; P = .782) did not demonstrate any significant associations with depression. For premature delivery, a convenience sample study design was associated with higher ORs (OR = 2.43; 95% CI, 1.47 to 4.01; P = .001).
Conclusions: Maternal depression during pregnancy is associated with increased odds for premature delivery and decreased breastfeeding initiation; however, the effects are modest. More research of higher methodological quality is needed.
© Copyright 2013 Physicians Postgraduate Press, Inc.
Similar articles
-
Maternal Anxiety During Pregnancy and the Association With Adverse Perinatal Outcomes: Systematic Review and Meta-Analysis.J Clin Psychiatry. 2018 Sep 4;79(5):17r12011. doi: 10.4088/JCP.17r12011. J Clin Psychiatry. 2018. PMID: 30192449
-
Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.JAMA Psychiatry. 2013 Apr;70(4):436-43. doi: 10.1001/jamapsychiatry.2013.684. JAMA Psychiatry. 2013. PMID: 23446732 Review.
-
Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis.JAMA Psychiatry. 2016 Aug 1;73(8):826-37. doi: 10.1001/jamapsychiatry.2016.0934. JAMA Psychiatry. 2016. PMID: 27276520 Review.
-
The combined effects of maternal depression and excess weight on neonatal outcomes.Int J Obes (Lond). 2015 Jul;39(7):1033-40. doi: 10.1038/ijo.2015.44. Epub 2015 Mar 30. Int J Obes (Lond). 2015. PMID: 25817069
-
Pregnancy and Delivery Outcomes Following Benzodiazepine Exposure: A Systematic Review and Meta-analysis.Can J Psychiatry. 2020 Dec;65(12):821-834. doi: 10.1177/0706743720904860. Epub 2020 Mar 9. Can J Psychiatry. 2020. PMID: 32148076 Free PMC article.
Cited by
-
Potentially modifiable risk and protective factors affecting mental and emotional wellness in pregnancy.Front Hum Neurosci. 2024 Feb 20;18:1323297. doi: 10.3389/fnhum.2024.1323297. eCollection 2024. Front Hum Neurosci. 2024. PMID: 38445095 Free PMC article.
-
Investigating maternal and neonatal health outcomes associated with continuing or ceasing dexamphetamine treatment for women with attention-deficit hyperactivity disorder during pregnancy: a retrospective cohort study.Arch Womens Ment Health. 2024 Mar 1. doi: 10.1007/s00737-024-01450-4. Online ahead of print. Arch Womens Ment Health. 2024. PMID: 38424254
-
Diagnosis of Perinatal Mental Health Conditions Following Medicaid Expansion to Include Low-Income Immigrants.JAMA Netw Open. 2024 Feb 5;7(2):e240062. doi: 10.1001/jamanetworkopen.2024.0062. JAMA Netw Open. 2024. PMID: 38376840 Free PMC article.
-
The impact of the affordable care act on perinatal mood and anxiety disorder diagnosis and treatment rates among Michigan Medicaid enrollees 2012-2018.BMC Health Serv Res. 2024 Jan 30;24(1):149. doi: 10.1186/s12913-023-10539-y. BMC Health Serv Res. 2024. PMID: 38291449 Free PMC article.
-
Interconception care during well-child visits by family physicians in the United States: A cross-sectional study.J Gen Fam Med. 2023 Nov 29;25(1):28-35. doi: 10.1002/jgf2.660. eCollection 2024 Jan. J Gen Fam Med. 2023. PMID: 38240006 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
